The sphingomyelin metabolites ceramide and sphingosine are mediators of cell death induced by c-irradiation. We studied the production of ceramide and the effects of exogenous ceramide on apoptosis in LNCaP prostate cancer cells that are highly resistant to c-irradiation-induced cell death. LNCaP cells can be sensitized to c-irradiation by tumor necrosis factor a (TNF-a) and, to a lesser degree, by the agonistic FAS antibody CH-11. TNF-a activated intrinsic and extrinsic apoptosis pathways and increased ceramide and sphingosine levels in irradiated LNCaP cells. CH-11 activated only the extrinsic apoptosis pathways and had a negligible effect on ceramide and sphingosine levels in irradiated LNCaP cells. Exogenous ceramide and bacterial sphingomyelinase sensitized LNCaP cells to radiation-induced apoptosis and had a synergistic effect on cell death after irradiation with TNF-a, but not with CH-11. Cell death effects after exposure to ceramide and irradiation were blocked by the serine protease inhibitor TLCK (Na-p-tosyl-L-lysinechloromethylketone), but not by the caspase inhibitor z-VAD (2-val-Ala-Asp(oMe)-CH 2 F). During LNCaP cell apoptosis induced by exogenous ceramide, we observed activation of caspase-9, but not caspases-8, -3, or -7. The effect of ceramide occurred largely via the intrinsic mitochondrial apoptosis pathway and enhanced TNF-a, but not CH-11 effects on irradiated cells. The data show that ceramide enhanced activation of the intrinsic apoptotic pathway and enhanced cell death induced by TNF-a with or without cirradiation. TNF-a and c-irradiation elevated levels of endogenous ceramide and activated the intrinsic cell death pathway.
Introduction
Activation of apoptosis by ligand binding to cell surface death receptors such as FAS or tumor necrosis factor a (TNF-a) results in the formation of the death-inducing signaling complex (DISC), which includes the cytoplasmic domain of the death receptor, Fas-associated death domain (FADD), caspase-8, and other adaptor proteins. 1, 2 Subsequent to formation of the DISC, caspase-8 is cleaved to initiate the proteolytic cascade that leads to apoptosis. FAS activation triggers a cascade termed the extrinsic pathway, which includes caspases-8 and -3, eventually cleaving Poly ADP Ribose Polymerase (PARP) and the inhibitor of DNA Fragmentation Factor (DFF), a DNase that generates nucleosomal DNA fragments that can be detected as DNA laddering.
2-8 TNF-a initiates a more complex set of signaling events that can include activation of the extrinsic cell death pathway. 9 ,10 TNF-a activation also triggers a separate antiapoptotic pathway via activation of nuclear factor kB (NF-kB) that probably explains the stimulation rather than execution of inflammatory cells by TNF-a. [11] [12] [13] [14] Induction of cell death by cellular injury or loss of survival signals is mediated predominantly by pathways that are intrinsic and can be triggered by a variety of stimuli leading to egress of cytochrome c from the mitochondria, activation of caspase-9 and subsequent death execution. 15, 16 The intrinsic and extrinsic pathways connect through a variety of mechanisms. For example, caspase-8 activation by death ligands can result in cleavage of BID that can complex with the antiapoptotic protein BAX, leading to mitochondrial egress of cytochrome c and activation of caspase-9. [17] [18] [19] [20] [21] Various insults to the cell can cause increased expression of FAS and/ or FAS ligand resulting in activation of caspase-8 and its downstream targets. [22] [23] [24] [25] In addition to activation of FASmediated signaling, apoptotic stimuli induce cells to produce other endogenous mediators of cell death such as the sphingolipid metabolite ceramide. 26, 27 In response to cell stress such as ionizing radiation, ceramide is produced by activation of either sphingomyelinases or ceramide synthases. [28] [29] [30] Ceramide production is not a universal phenomenon and appears to have a proapoptotic role in certain cell types. 30, 31 Cellular levels of both ceramide and its metabolite sphingosine, are increased after exposure of LNCaP prostate cancer cells to TNF-a and irradiation. We have shown that LNCaP prostate cancer cells are highly resistant to radiation-induced apoptosis. However, irradiation sensitizes LNCaP cells to apoptosis induction by either TNF-a or FAS. 32, 33 Here we confirm that ceramide production in irradiated LNCaP cells is induced by TNF-a and show that the FAS agonist, antibody CH-11, does not cause ceramide production during the execution of cell death. Addition of exogenous C 2 -ceramide or bacterial sphingomyelinase enhances cell death induced by TNF-a, but has no effect on cell death induced by CH-11 in the absence or presence of irradiation. This implies that an activation threshold exists for the proapoptotic effects of ceramide on LNCaP cells and that these cells can respond to ceramide only under some conditions of apoptosis induction. Those proapoptotic effects lead to mitochondrial depolarization, the activation of serine proteases, and caspase-9 activation.
Results

Production of sphingomyelin metabolites after treatment of LNCaP cells with death ligands
LNCaP prostate cancer cells are highly resistant to apoptosis induced by g-irradiation.
32,34 Both TNF-a and the agonistic FAS antibody CH-11 sensitize LNCaP cells to irradiationinduced apoptosis. 32 TNF-a plus irradiation increased levels of sphingosine and ceramide, 32, 35 but CH-11 alone or with irradiation had no effect on either sphingosine or ceramide content ( Figure 1 ). TNF-a and irradiation activate both the death-ligand-dependent extrinsic and the mitochondriamediated intrinsic apoptosis pathways. In LNCaP and other cell lines, the intrinsic cell death pathway leads to activation of both caspases and serine proteases, which in the case of LNCaP cells cause about 50% apoptosis. 32 In contrast, CH-11 plus irradiation induces cell death predominantly via the extrinsic apoptosis signaling pathway. 32, 33 We next sought to determine the role of ceramide in mediating LNCaP cell death.
Effect of ceramide on LNCaP cell death
Exogenous C 2 -ceramide induces a low level of apoptosis in LNCaP cells that sensitizes the cells to g-irradiation. 32 As can be seen in Figure 2a , the pancaspase inhibitor z-VAD (z-ValAla-Asp(OMe)-CH 2 F) had no effect on C 2 -ceramide-induced cell death. Exposure to higher doses of z-VAD inhibited cell death induced by C 2 -ceramide alone, but not by C 2 -ceramide together with irradiation ( Figure 2b ). On the other hand, the serine protease inhibitor TLCK (Na-p-tosyl-L-lysine-chloromethylketone) inhibited induction of LNCaP cell death after exposure to C 2 -ceramide and irradiation (Figure 2c ). We characterized caspase activation in LNCaP cells after exposure to C 2 -ceramide and irradiation. As can be seen on the left side of Figure 3 , C 2 -ceramide and irradiation induce a low level of caspase-9 activation, but not caspases-8 or -7 activation, suggesting that ceramide activated the intrinsic cell death pathway. The serine protease inhibitor TLCK inhibited caspase-9 activation after exposure of LNCaP cells to C 2 -ceramide plus irradiation, suggesting that the effect of C 2 -ceramide on cell death is mediated via serine protease activation that is upstream of caspase-9 activation (Figure 3 ). C 2 -ceramide potentiates TNF-a-mediated more than CH-11-mediated apoptosis Since C 2 -ceramide predominantly activated the intrinsic cell death pathway, we determined whether it could enhance cell death induced by activation of death receptors. A significant effect of C 2 -ceramide could be seen in irradiated cells treated with either CH-11 or TNF-a. At 24 h after exposure, a time when there is little to no cell death in LNCaP cells treated with either TNF-a or CH-11, C 2 -ceramide in combination with CH-11 resulted in more than 30% cell death and in combination with TNF-a, more than 90% cell death (Figure 4a ). These results suggest that C 2 -ceramide had a more profound effect on the intrinsic pathway in TNF-a-treated cells, perhaps because TNF-a also activated the intrinsic pathway and affected endogenous ceramide production and ceramide responsiveness, whereas CH-11 did not. Expression of dominant negative mutant of FADD (FADD-DN) completely blocked apoptosis after exposure to C 2 -ceramide with or without TNF-a, CH-11 and irradiation. The protective effect of FADD-DN on ceramide-mediated cell death was similar to the effects seen with cells exposed to TNF-a or TNF-a with irradiation. 33 FADD-DN expression was used as a way to block the extrinsic cell death pathway in order to demonstrated that FADD activation and the extrinsic pathway were Gy irradiation, and 300 mU/ml bacterial sphingomyelinase as indicated agreement with previous studies. 33 C 2 -ceramide had a minimal effect on caspase-8 activation in the presence of TNF-a or TNF-a with CH-11, with or without irradiation. Similarly, cleavage of caspase-3 and DFF-45, both downstream of caspase-8, [36] [37] [38] [39] were minimally affected by the presence of C 2 -ceramide. In contrast, the effect of C 2 -ceramide was much more pronounced on activation of caspases-7 and -9. Caspase-9 cleavage was observed in cells treated with TNF-a, but not with CH-11. Radiation enhanced caspase-9 cleavage induced by TNF-a. C 2 -ceramide alone had no detectable effect on caspase-9 at 24 h after treatment. However, C 2 -ceramide markedly enhanced caspase-9 cleavage induced by TNF-a in the presence or absence of irradiation. CH-11 did not activate caspase-9 cleavage alone or in the presence of C 2 -ceramide.
Although CH-11 did not induce detectable caspase-7 cleavage at 24 h after treatment, in the presence of C 2 -ceramide, there was significant caspase-7 activation. TNF-a treatment induced greater caspase-7 activation than CH-11. Irradiation enhanced caspase-7 cleavage under all circumstances except after exposure to CH-11 alone or C 2 -ceramide alone. Interestingly, despite the activation of caspase-3 in LNCaP cells treated with CH-11, PARP cleavage was not evident. In irradiated LNCaP cells, PARP cleavage paralleled caspase-7 activation, consistent with reports that caspase-7 is the predominant effector caspase in LNCaP cells. 33, 34, 40 We note that the proapoptotic protein BAX was also cleaved concomitantly with caspase-7 activation.
Taken together with the data in Figures 2 and 3 , these results imply that C 2 -ceramide activated the intrinsic cell death pathway mediated by casapses-9 and -7 downstream of serine protease activation. TNF-a had a greater effect on the intrinsic pathway mediated by caspases-8, -9, and -7 and BAX, while CH-11 affected the extrinsic pathway including caspases-8, -3, and DFF-45. C 2 -ceramide, which activated the intrinsic pathway, potentiated the effects of TNF-a more than those of CH-11.
The role of caspase-9 in cell death enhancement by C 2 -ceramide was studied using the caspase-9 inhibitor LEHD (Nacetyl-Leu-Glu-His-Asp-Cuo) that had no effect on LNCaP cell death induced by CH-11 in the absence or presence of irradiation. In contrast, z-VAD completely blocked CH-11-induced apoptosis (Figure 6a ). This result is consistent with the observation that caspase-9 was not activated by CH-11 in the absence or presence of irradiation. LEHD partially inhibited apoptosis induced by TNF-a and irradiation. The failure of LEHD to block apoptosis completely was likely because of the activation of serine proteases by TNF-a with irradiation, as we have shown previously. 32 To confirm the presence of activated serine proteases, we used the granzyme and serine protease inhibitor AAD (2-Ala-Asp(OMe)-CH 2 F). Combined treatment with AAD and LEHD blocked LNCaP cell death completely (Figure 6b ). Collectively, these results imply that serine protease activation occurred upstream from mitochondrial activation and was able to mediate some degree of cell death, even in the presence of LEHD. In contrast, LNCaP cell death after simultaneous treatment with CH-11 and TNF-a in the absence or presence of irradiation, occurs within 24 h and requires only caspase activation. 33 Under these conditions, either the caspase-8 inhibitor IETD (z-Ile-Glu-Thr-Asp(OMe)-CH 2 F) or the caspase-9 inhibitor LEHD were equally effective at inhibiting cell death, indicating that activation of caspase-9 via upstream caspase-8 is the predominant proteolytic cell death program (Figure 6c ).
Attenuation of the intrinsic pathway interferes with the effect of ceramide
Stable expression of IkBSR, a constitutively active inhibitor of NF-kB, in LNCaP cells results in inhibition of apoptosis induced by TNF-a in the presence or absence of irradiation. IkBSR expression inhibits NF-kB activity and results in blockade of serine protease activation, an event upstream of mitochondrial activation in the intrinsic cell death pathway. 25 We used LNCaP cells stably transfected with IkBSR because these cells have a strong block of the intrinsic apoptosis pathway. IkBSR expression in LNCaP cells also blocked the increase in ceramide levels after cells were exposed to TNF-a and irradiation, suggesting that NF-kB activity was necessary for the response to irradiation (Figure 7a) . 32, 41, 42 Increasing ceramide levels by treating LNCaP(IkBSR) cells with bacterial sphingomyelinase was still able to activate cell death, but to a Interruption of the intrinsic apoptosis pathway in LNCa-P(IkBSR) cells was further elucidated by analysis of mitochondrial membrane depolarization (DC m ). Increased DC m is a sensitive indicator of LNCaP cell exposure to apoptotic stimuli. 34 In fact, 20 Gy irradiation alone, that otherwise has no measurable effect on induction of apoptosis, increased DC m in LNCaP cells (Figure 8a ). More importantly, expression of IkBSR abrogated all increases in DC m after exposure of LNCaP cells to irradiation and/or TNF-a. Expression of FADD-DN also blocked the effect of TNF-a alone on the change in DC m , but had no effect on the response to 20 Gy irradiation (Figure 8a ). Inhibition of caspase-8 with IETD also markedly reduced the effect of TNF-a on DC m , but had no effect on irradiation alone and caused only a small attenuation after TNF-a and irradiation (Figure 8b ). IkBSR expression had no effect on the ability of the cells to respond to ceramide itself, indicating that IkBSR acts upstream of ceramide generation (Figure 8c) .
Inhibition of the intrinsic pathway by IkBSR expression was also demonstrated by analysis of caspase activation after cells were treated with TNF-a in the absence or presence of 20 Gy. These treatments attenuated the cell death response of LNCaP cells expressing IkBSR. 25 Caspase-3 was activated during induction of apoptosis, even to a higher degree than in control cells (Figure 9 ). However, activation of caspases-9 and -7 were blocked by IkBSR expression.
Discussion
Our results show that in LNCaP prostate adenocarcinoma cells, TNF-a and FAS have different effects on ceramide production. C 2 -ceramide or bacterial sphingomyelinase augment the effects of endogenous ceramide in LNCaP cells treated with TNF-a and irradiation, but not CH-11 together with irradiation. This implies that TNF-a not only increased ceramide levels, but also triggered a ceramide-responsive state that was not activated by CH-11 in LNCaP cells. This interpretation is consistent with findings in other cell systems that sphingomyelinase activation is dependent on cas- pases. [43] [44] [45] In irradiated LNCaP cells, CH-11 did not activate the intrinsic death pathway or sufficiently increase cellular ceramide or sphingosine. In contrast, TNF-a activated both the intrinsic pathway and ceramide production. Irradiation of LNCaP cells had no effect on ceramide production. We propose that in LNCaP cells, increased ceramide activates a secondary death pathway that amplifies a cell death signal and follows caspase activation.
We observed that the effects of ceramide were mediated by serine proteases, inhibitable by TLCK and AAD and manifested by mitochondrial membrane depolarization and caspase-9 activation. The addition of short-chain ceramides to isolated mitochondria or to cell cultures has been reported to induce direct inhibition of complex III of the mitochondrial respiratory chain, the generation of reactive oxygen species, cytochrome c release and a decrease in transmembrane potential. 46, 47 The effects of short-chain ceramides can also be blocked by Bcl-2. 48 Therefore, it is likely that ceramide responsiveness is mediated through a mitochondria-dependent death pathway. Exogenous ceramide has also been shown to promote capping of FAS on the cell surface, thereby sensitizing cells to death complex formation. 49 However, even though irradiation and TNF-a both increase expression of FAS on the surface of LNCaP cells, 25 we did not detect sensitization of LNCaP cells to CH-11-induced apoptosis by C 2 -ceramide, consistent with the notion that sensitization to the proapoptotic effects of ceramide on LNCaP cells affected the intrinsic cell death pathway.
We have also considered that ceramide responsiveness could have been activated by different degrees of signaling downstream from caspase-8. Both TNF-a and FAS activate caspase-8 by mechanisms that are qualitatively different. 33 Importantly, LNCaP cell death induced by CH-11 and irradiation can be inhibited by the caspase-8 inhibitor IETD, but not LNCaP cell death induced by TNF-a plus irradiation 25 (our unpublished observations). Therefore, apoptosis pathways downstream from caspase-8 are likely to be differentially activated by TNF-a and CH-11 in LNCaP cells.
CH-11 together with irradiation induced caspases-8, -3, and DFF-45 activation. In contrast, TNF-a plus irradiation induced activation of caspases-9 and -7 and BAX cleavage. These disparate apoptotic pathways are reminiscent to the type 1 and type 2 pathways of FAS-induced apoptosis proposed by Scaffidi. 50 Type 1 cells undergo apoptosis by activation of caspase-8 followed by activation of caspase-3 and this is not blocked by ectopic expression of Bcl-2 or Bcl-X L . In type 2 cells, there is diminished formation of the DISC and apoptosis is mediated by BAX-induced mitochondrial egress of cytochrome c and activation of caspase-9. C 2 -ceramide induced apoptosis only in the type 2 cells such as CEM and Jurkat, whereas C 2 -ceramide was inactive in type 1 cells, such as SKW6.4 and H9. 51 In the case of LNCaP cells, we have observed activation of type 1 or type 2 apoptosis depending on exposure of irradiated cells to CH-11 or TNF-a, respectively.
The analogy with Scaffidi's findings is limited by the relative resistance of LNCaP cells to induction of cell death and the importance of serine proteases in the mediation of some of Caspase-7 -p37 -p20 -p20 Figure 9 Western blotting for caspases-3, -7, and -9 in parental and transfected LNCaP cells either 24 h (caspase-3) or 72 h (caspases-7 and -9) after treatment with 40 ng/ml TNF-a and 20 Gy irradiation. The Western blots show only activated caspases as designated on the right the apoptotic effects of TNF-a. In LNCaP cells there was also preferential activation of caspase-7 by TNF-a plus irradiation and of caspase-3 by CH-11 plus irradiation. We and others have previously observed that caspase-7 is activated in LNCaP cells by a variety of proapoptotic agonists. 32, 40 In type 2 CEM and Jurkat cells, caspase-9 and cleavage apoptosis was accompanied by activation of both caspases-7 and -3.
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Since caspase-3 is activated within 24 h of LNCaP cell exposure to TNF-a and cycloheximide, it is likely that LNCaP cells express a protein that limits caspase-3 activation. 52 The influence of cell type on choice of apoptosis pathways is further illustrated by experiments with C 2 -ceramide and FAS treatment of glioma cells that led to cleavage of caspases-3, -8, and -9 and cytochrome c release. 53 Therefore, in the proper cellular milieu, FAS can activate mitochondrial apoptosis pathways and can interact with ceramide. Of note is that ceramide-induced activation of the intrinsic mitochondrialdependent pathway in LNCaP cells whereas there was no activation of the extrinsic pathway. This is in contrast to many reports that ceramide production can both activate and be activated by the extrinsic apoptosis pathway. [54] [55] [56] [57] Once again, we believe that differences between our findings and other cell systems are explained by differences in cellular milieu.
Ceramide-induced LNCaP cell death was caspase-independent since it was not blocked by the pancaspase inhibitor z-VAD. Ceramide has been shown to induce caspasedependent cell death in many systems, but can also induce necrotic glioma cell death that can be blocked by an AKTdependent survival signal. 58 In glioma cells, ceramide failed even to induce mitochondrial depolarization. In contrast, both ceramide and its metabolite GD3 have generally been shown to induce mitochondrial depolarization. 59, 60 Activation of mitochondria was likely mediated by BAX, as it was cleaved after exposure of cells to TNF-a and irradiation. BAX can also be a target for a variety of proteases. We did not determine whether serine proteases, caspase-8, or some other caspase was responsible for BAX cleavage in LNCaP cells, although BAX has been reported not to be a target of caspase-3. 61 Ceramide has also been shown to cause clumping of CD95 on the cell surface 62, 63 CD95 aggregation facilitates death signaling. We did not observe any effect of ceramide on cell death mediated by FAS after CH-11 exposure. In LNCaP cells ceramide had a profound effect on apoptosis induced by TNFa and irradiation. Our data imply that the major effect of ceramide on the effect of death ligands was via the intrinsic mitochondrial pathway and caspase-9 activation and not by any effect on death receptors that should have been manifested through the activation of caspases-8 and -3.
This study has demonstrated that serine protease activation is integral to LNCaP cell death induction by TNF-a and irradiation. A proapoptotic serine protease Omi/HtrA2 has recently been found to be released from mitochondria as a result of a number of apoptotic stimuli. [64] [65] [66] One target of Omi/ HtrA2 is XIAP, an antiapoptotic protein that is sequestered by Smac, a mitochondrial proapoptotic protein. [67] [68] [69] [70] [71] [72] In LNCaP cells, microinjection of either cytochrome c or Smac alone are insufficient to induce substantial apoptosis, but combined, the two are proapoptotic. 73 Our data imply that serine protease activation is upstream from caspase-9 activation in LNCaP cells and therefore may have been responsible for apoptosis mediated by cytochrome c and Smac egress from the mitochondria.
We have observed that stable expression of IkBSR is antiapoptotic in LNCaP cells. 25 This is in contrast to findings of others that IkBSR sensitizes cells to TNF-a induction of apoptosis. 74 Differences in the effects of IkBSR may be because of differences in levels of NF-kB activity in the transfected cells or because of differences between laboratory strains of LNCaP cells. Our use of LNCaP(IkBSR) cells in this study was solely for the purpose of exploiting cell lines that have been shown to have attenuated activation of intrinsic apoptosis pathways after exposure to TNF-a7g-irradiation.
Materials and Methods
Cell culture and cell death induction
Culture of LNCaP cells and induction and assay of apoptosis with TNF-a, CH-11, and irradiation has been previously described. [32] [33] [34] LNCaP cells were used at early passages starting at passage 20 from a large frozen stock maintained in our laboratory for more than a decade. Generally, LNCaP parental cells were used prior to passage 50. Derivative LNCaPtransfected cells were used after confirmation that their properties were stable. Toward this end, all experiments were performed a minimum of three times. For experiments that required addition of either C 2 -ceramide or bacterial sphingomyelinase, the medium was changed from modified IMEM containing 5% FCS to modified IMEM without serum 24 h before treatment with death ligands and/or radiation. LNCaP cells stably transfected with FADD-DN and IkBSR have been previously described.
25,33
Measurement of ceramide and sphingosine
Assays for cellular levels of the sphingolipid metabolites ceramide and sphingosine have been previously described. 32, 35 Lipids were separated by thin-layer chromatography and the radioactive bands were quantitated using a Molecular Dynamics phosphorimage analyzer (Sunnyvale, CA, USA). The amount of ceramide content in each sample was standardized based upon the amount of phospholipids determined by standard methods. 75 Experiments were performed three times.
Western blotting
Blotting and antibodies used in these experiments have been previously described. 34 
Measurement of mitochondrial membrane depolarization
Assay of mitochondrial membrane depolarization and calculation of DC m has been previously described. 34 The assay was performed by using the DePsipher kit (Trevigen, Gaithersburg, MD, USA). 76 Briefly, the cells were collected and washed with PBS(À), and suspended in DePsipher (JC-1, 5,5 0 ,6,6 0 -tetrachloro-1,1 0 ,3,3 0 -tetraethyl-benzimidaxolylcarbocyanine iodide) solution (final concentration 5 mg/ml). After incubation at 371C for 20 min, the samples were washed with PBS(À) twice and analyzed at 488 nm argon laser by flow cytometry (FACStar plus, Beckton Dickinson, San Diego, CA, USA).
